LncRNA: a link between RNA and cancer
G Yang, X Lu, L Yuan - Biochimica et Biophysica Acta (BBA)-Gene …, 2014 - Elsevier
Unraveling the gene expression networks governing cancer initiation and development is
essential while remains largely uncompleted. With the innovations in RNA-seq technologies …
essential while remains largely uncompleted. With the innovations in RNA-seq technologies …
Long noncoding RNAs as biomarkers in cancer
L Bolha, M Ravnik-Glavač, D Glavač - Disease markers, 2017 - Wiley Online Library
Long noncoding RNAs (lncRNAs) are a relatively well‐characterized class of noncoding
RNA (ncRNA) molecules, involved in the regulation of various cell processes, including …
RNA (ncRNA) molecules, involved in the regulation of various cell processes, including …
[HTML][HTML] Long noncoding RNAs: cellular address codes in development and disease
PJ Batista, HY Chang - Cell, 2013 - cell.com
In biology as in real estate, location is a cardinal organizational principle that dictates the
accessibility and flow of informational traffic. An essential question in nuclear organization is …
accessibility and flow of informational traffic. An essential question in nuclear organization is …
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
Purpose Given the limited sensitivity and specificity of prostate-specific antigen (PSA), its
widespread use as a screening tool has raised concerns for the overdiagnosis of low-risk …
widespread use as a screening tool has raised concerns for the overdiagnosis of low-risk …
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian …
Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …
A rich array of prostate cancer molecular biomarkers: opportunities and challenges
I Kohaar, G Petrovics, S Srivastava - International journal of molecular …, 2019 - mdpi.com
Prostate cancer is the most prevalent non-skin cancer in men and is the leading cause of
cancer-related death. Early detection of prostate cancer is largely determined by a widely …
cancer-related death. Early detection of prostate cancer is largely determined by a widely …
APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer
J Groskopf, SMJ Aubin, IL Deras, A Blase… - Clinical …, 2006 - academic.oup.com
Background: Prostate cancer gene 3 (PCA3) encodes a prostate-specific mRNA that has
shown promise as a prostate cancer diagnostic tool. This report describes the …
shown promise as a prostate cancer diagnostic tool. This report describes the …
PCA3: a molecular urine assay for predicting prostate biopsy outcome
IL Deras, SMJ Aubin, A Blase, JR Day, S Koo… - The Journal of …, 2008 - auajournals.org
Purpose: A urinary assay for PCA3, an mRNA that is highly over expressed in prostate
cancer cells, has shown usefulness as a diagnostic test for this common malignancy. We …
cancer cells, has shown usefulness as a diagnostic test for this common malignancy. We …
lncRNAs: insights into their function and mechanics in underlying disorders
X Li, Z Wu, X Fu, W Han - Mutation Research/Reviews in Mutation …, 2014 - Elsevier
Genomes of complex organisms are characterized by the pervasive expression of different
types of noncoding RNAs (ncRNAs). lncRNAs constitute a large family of long—arbitrarily …
types of noncoding RNAs (ncRNAs). lncRNAs constitute a large family of long—arbitrarily …
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
LS Marks, Y Fradet, IL Deras, A Blase, J Mathis… - Urology, 2007 - Elsevier
OBJECTIVES: Men with elevated serum prostate-specific antigen (PSA) levels and negative
prostate biopsy findings present a dilemma because of the lack of an accurate diagnostic …
prostate biopsy findings present a dilemma because of the lack of an accurate diagnostic …